Related Experiment Video
Updated: Aug 18, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Evaluation of the practical use of the Becton-Dickinson (B-D) insulin pen injector]
1Katedry i Kliniki Chorób Metabolicznych Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
Unlabelled:
The aim of this study was to assess insulin pen-injector in respect to: 1) improvement of metabolic control of diabetic patients, 2) improvement quality of life as well as complications connected with the use of pen patients. 23 IDDM and 7 NIDDM patients were enrolled to the study. Monthly check-up, control of diabetic complications, biochemical tests and glycemic profile and level of HbA1 c were performed. Human insulin containers of Eli Lilly-were used with the pens. Each month the glycemic profile and after 3 months HbA1c were tested. Special questionnaire was used to gather patients comments and remarks on the use of pens.
Results:
1. After 3 months of the pen use the mean levels of glucose were lower as well as the level of HbA1c. 2. Patients found the pens as easy and convenient way of insulin use, impairing their comfort of life. The moment of initiation of B-D pen injector was combined with the intensive insulin therapy, application of human insulin and both education and self-control. The assessment of the one only parameter among the others is hardly possible nevertheless it should be stressed that in intensive conventional insulin therapy, insulin pen injector was found as practical element improving treatment regimen.
Related Concept Videos
Insulin Secretory Vesicles
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

